In breaking groups according to sex, male G2019S-LRRK2 mutation carriers with PD had higher pS1292-LRRK2/Tsg101 levels than in carriers without PD (~8.9 fold versus ~3.8 fold, p=0.04). Here, LRRK2 is linked to Parkinson disease.